Abstract
The present invention relates to crystalline form of N-(5-{4-[(1,1-dioxidothiomorpholin-4-yl)methyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropane carboxamide, maleate of formula-1 referred to as Filgotinib maleate, which is represented by the following structural formula.
Publication Date
2026-01-04
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center, Hyderabad, India, Srinivasan Thirumalai Rajan, KESHAVAREDDY, Navin Kumar Reddy, Dr. P. Raja Gopal, V.Dathatreya, "Process for the preparation of Filgotinib maleate", Technical Disclosure Commons, (January 04, 2026)
https://www.tdcommons.org/dpubs_series/9125
COinS